These results suggest that increased interactions of CD4+ T cells with microglia, myeloid and tumor cells may promote the acquisition of memory signature by CD4+ T cells after M002 treatment, which could be facilitated by the MHCII signals provided from the tumor cells. The gene discussed is CD4; the disease is neoplasm.